CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Trastuzumab and Pertuzumab (FDC SC) and T-DM1

Phase 2
Roche Holding AG (RHHBY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
RHHBYPhase 2

Trastuzumab and Pertuzumab (FDC SC) and T-DM1 Phase 2 Est. Readout

Trastuzumab and Pertuzumab (FDC SC) and T-DM1
Mar 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Early Breast Cancer

View Full Landscape
Drug Information

Target Indication

Early Breast Cancer

Clinical Trial

NCT04733118

Last updated: 10/8/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.